<DOC>
	<DOCNO>NCT02557971</DOCNO>
	<brief_summary>This study retrospective chart review patient treat BOTOX® idiopathic Overactive Bladder ( OAB ) standard care clinical practice . The study determine rate post procedural urinary retention require catheterization identify factor may predict urinary retention .</brief_summary>
	<brief_title>Urinary Retention Rates Clinical Practice After Treatment With OnabotulinumtoxinA Idiopathic Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Patients treat BOTOX® Overactive Bladder . Received botulinum toxin formulation BOTOX® bladder . Had symptom OAB associate neurological condition . Had history chronic urinary retention treat Clean Intermittent Catheterization ( CIC ) indwell catheter .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>